{
  "main_header": {
    "sid": 1125492,
    "name": "MediWound Ltd.",
    "stock_name": "MediWound Ltd.",
    "full_name": "MediWound Ltd.",
    "name_url": "stocks-analysis/mediwound",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "17.98",
    "chg": 0.63,
    "chgp": "3.63%",
    "dir": 1,
    "prev_price": "17.35",
    "mcapval": "180.92",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "IL0011316309",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "247.26 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mediwound-1125492-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "MediWound Ltd. Forms Death Cross, Signaling Potential Bearish Trend Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mediwound-ltd-forms-death-cross-signaling-potential-bearish-trend-ahead-3559446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/MediWound_dealthcross_3559446.png",
        "date": "2025-09-23 15:40:05",
        "description": "MediWound Ltd., a microcap in the Pharmaceuticals & Biotechnology sector, has recently encountered a Death Cross, indicating a potential shift in market sentiment. Technical indicators suggest a bearish outlook, with declining moving averages and negative momentum, while the stock's one-year performance significantly lags behind the S&P 500."
      },
      {
        "title": "Is MediWound Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mediwound-ltd-technically-bullish-or-bearish-3546884",
        "imagepath": "",
        "date": "2025-09-20 19:42:22",
        "description": "As of 12 September 2025, the technical trend for MediWound Ltd. has changed from mildly bullish to mildly bearish. The weekly MACD and KST indicators are bearish, while the monthly MACD and KST are mildly bearish. The daily moving averages indicate a mildly bullish stance, but overall, the weekly Bollinger Bands are bearish, and the monthly Bollinger Bands are sideways. The Dow Theory shows a mildly bearish trend on the monthly timeframe. \n\nIn terms of performance, MediWound has underperformed the S&P 500 across multiple periods, with a year-to-date return of -3.09% compared to the S&P 500's 12.22%, and a one-year return of -1.82% versus 17.14%. Overall, the current technical stance is mildly bearish...."
      },
      {
        "title": "Is MediWound Ltd. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mediwound-ltd-overvalued-or-undervalued-3543368",
        "imagepath": "",
        "date": "2025-09-20 18:17:32",
        "description": "As of 6 August 2020, the valuation grade for MediWound Ltd. changed from attractive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its significant negative financial metrics, including a Price to Book Value of 7.46, an EV to EBIT of -9.39, and an EV to EBITDA of -10.10. These ratios suggest that the company's valuation does not align with its current financial performance.\n\nIn comparison to its peers, MediWound Ltd. has a worse EV to EBITDA ratio than Esperion Therapeutics, Inc. at -28.9150 and a higher Price to Book Value than Oramed Pharmaceuticals, Inc. at 0.2489. The negative ROE of -67.86% further underscores the company's struggles relative to its industry. While recent stock performance data is not available for a direct comparison with the S&P 500, the overall financial indicators suggest that MediWound Ltd. is currently overvalu..."
      }
    ],
    "total": 8,
    "sid": "1125492",
    "stock_news_url": "https://www.marketsmojo.com/news/mediwound-1125492"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

MediWound Ltd. Forms Death Cross, Signaling Potential Bearish Trend Ahead

2025-09-23 15:40:05

MediWound Ltd., a microcap in the Pharmaceuticals & Biotechnology sector, has recently encountered a Death Cross, indicating a potential shift in market sentiment. Technical indicators suggest a bearish outlook, with declining moving averages and negative momentum, while the stock's one-year performance significantly lags behind the S&P 500.

Read More

Is MediWound Ltd. technically bullish or bearish?

2025-09-20 19:42:22

As of 12 September 2025, the technical trend for MediWound Ltd. has changed from mildly bullish to mildly bearish. The weekly MACD and KST indicators are bearish, while the monthly MACD and KST are mildly bearish. The daily moving averages indicate a mildly bullish stance, but overall, the weekly Bollinger Bands are bearish, and the monthly Bollinger Bands are sideways. The Dow Theory shows a mildly bearish trend on the monthly timeframe. In terms of performance, MediWound has underperformed the S&P 500 across multiple periods, with a year-to-date return of -3.09% compared to the S&P 500's 12.22%, and a one-year return of -1.82% versus 17.14%. Overall, the current technical stance is mildly bearish....

Read More

Is MediWound Ltd. overvalued or undervalued?

2025-09-20 18:17:32

As of 6 August 2020, the valuation grade for MediWound Ltd. changed from attractive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its significant negative financial metrics, including a Price to Book Value of 7.46, an EV to EBIT of -9.39, and an EV to EBITDA of -10.10. These ratios suggest that the company's valuation does not align with its current financial performance. In comparison to its peers, MediWound Ltd. has a worse EV to EBITDA ratio than Esperion Therapeutics, Inc. at -28.9150 and a higher Price to Book Value than Oramed Pharmaceuticals, Inc. at 0.2489. The negative ROE of -67.86% further underscores the company's struggles relative to its industry. While recent stock performance data is not available for a direct comparison with the S&P 500, the overall financial indicators suggest that MediWound Ltd. is currently overvalu...

Read More

View All News